PubMed ID:
20067954
Public Release Type:
Journal
Publication Year: 2010
Affiliation: Barbara Davis Center for Childhood Diabetes, University of Colorado at Denver, Aurora, Colorado, USA. peter.gottlieb@ucdenver.edu
DOI:
https://doi.org/10.2337/dc09-1349
Authors:
Gottlieb PA,
Greenbaum CJ,
Krause-Steinrauf H,
Lachin JM,
Moran AM,
Quinlan S,
Rodriguez H,
Schatz DA,
Skyler JS,
Type 1 Diabetes TrialNet MMF/DZB Study Group,
Wilson DM
This trial tested whether mycophenolate mofetil (MMF) alone or with daclizumab (DZB) could arrest the loss of insulin-producing beta-cells in subjects with new-onset type 1 diabetes.